<DOC>
	<DOCNO>NCT00713661</DOCNO>
	<brief_summary>The primary objective evaluate application TachoSil® colorectal anastomosis feasible safe . The secondary objective establish describe optimal application method use educational purpose future trial .</brief_summary>
	<brief_title>Evaluation TachoSil® Application Colorectal Anastomosis ( TC-029-IM )</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria screening : Has patient give informed consent accord local requirement trialrelated activity ? A trialrelated activity procedure would perform routine management subject . Is subject 18 year age ? Is subject scheduled elective resection rectum ? Is colorectal anastomosis peritoneal reflexion plan ? For female childbearing potential : Does patient use acceptable contraceptive method ( contraceptive pill , injection prolong gestagen , subdermal implantation , hormonal vaginal device , transdermal patch intrauterine device ( IUD ) ) ? Is blood urine pregnancy test negative ? Exclusion Criteria screening : Is subject scheduled emergency resection rectum ? Does subject suffer inflammatory bowel disease ? Does subject history hypersensitivity reaction application human fibrinogen , human thrombin and/or collagen origin ? Has subject participate trial investigational medical product ( IMP ) device within 30 day inclusion trial ? Does subject participate plan participate another clinical trial trial period ? For female childbearing potential : • Is subject pregnant breast feeding ? Exclusion peroperative Was anastomosis perform differently define inclusion criterion ? Did subject receive fibrin sealant/glue , exclude TachoSil® , surgery ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Colorectal Anastomosis</keyword>
	<keyword>Colorectal Resection</keyword>
	<keyword>Tachosil</keyword>
</DOC>